Thursday, December 2, 2021
NEW LONDON, CT (December 2, 2021) - The Auxiliary of Lawrence + Memorial Hospital has kicked off this year’s “Lights of Hope” fundraising campaign which invites members of the community to make gifts of any amount in honor or remembrance of a loved one.
Lights will adorn a tree which will be on display on L+M Hospital grounds beginning the evening of December 14.
For information or to request a donation form for the Lights of Hope campaign, email Kathryn Greene at [email protected].
Lawrence + Memorial Hospital, a member of Yale New Haven Health, is a non-profit, 308-bed general and acute care hospital providing patient care to medical, surgical, pediatric, psychiatric and obstetrical patients in southeastern Connecticut and southern Rhode Island since 1912. Lawrence + Memorial offers cardiac acute, step-down and rehabilitation programs and is the only eastern Connecticut hospital that performs emergency and elective angioplasty. www.lmhospital.org
1/15/2026
Bridgeport Hospital recognized with two Beacon Awards for ExcellenceMILFORD, CT (January 15, 2026) – The American Association of Critical-Care Nurses (AACN) has recognized the Progressive Care Unit (PCU) and the Medical-Coronary Intensive Care Unit (MICU) at Bridgeport Hospital with silver-level Beacon Awards for Excellence.
1/13/2026
Experienced Yale psychiatrist Kourtney Koslosky, MD, tapped to lead Greenwich Hospital’s Psychiatry and Behavioral Health DepartmentGREENWICH, CT (December 4, 2025) - In October 2025, Greenwich Hospital appointed Kourtney Koslosky, MD, as the new chair of its Psychiatry and Behavioral Health department. With more than a decade of experience at Yale School of Medicine (YSM) and the Yale New Haven Health System (YNHHS), Dr. Koslosky brings both academic and clinical expertise to her new leadership post.
1/13/2026
Yale New Haven Health offers new technology to detect coronary artery diseaseNew Haven, CT (Jan. 12, 2026) — Yale New Haven Health is the first health system in Connecticut to offer a new positron emission tomography (PET) imaging agent that offers the potential to significantly enhance clinicians’ ability to detect coronary artery disease.
Fiona Phelan
203-780-1993
860-271-4634
[email protected]
